Pharmaceutical products and new lactosyl compounds and the preparation thereof
CA 1329591 C · Owner: Solco Basel Ag · Inventors: Wendel, Albrecht; Schmidt, Richard R.; Baer, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The compounds of the formula I exert a pronounced specific cytoprotective effect; they can be used for the treatment of acute and chronic inflammations and organ ischemias caused by narrowing of vessels. R1 denotes an aliphatic radical having 9 to 19 C atoms in the straight chain, R2 denotes the acyl radical of a saturated or unsaturated fatty acid having 14 to 24 C atoms and X, denotes a -CH2CH2- or -CH=CH- group. The invention relates to pharmaceutical products in which the active ingredient is the said compounds, as well as to those compounds I in which R2 denotes the acyl radical of an unsaturated fatty acid, and to the process for the preparation thereof. (I)
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 17, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 17, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.